Nina-Louisa Efrém holds a Bachelor’s degree in Biochemistry from Freie Universität Berlin. She obtained her Master’s degree in Drug Design and Synthesis from Vrije Universiteit Amsterdam. After her studies, she participated in the Roche internship in Medicinal Chemistry (RiCH) program in Basel, Switzerland. Nina-Louisa joined the Medicinal Chemistry research group at the Leibniz Institute for Molecular Pharmacology as a PhD student in October 2021. Her projects focus on the development of tool compounds for SHP2 and for C-type lectin receptors. She is an Early-Stage Researcher within the Marie Skłodowska-Curie innovative training network ALLOstery in Drug Discovery (ALLODD).
Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling
Angewandte Chemie 2021read online
Progress in Free Energy Perturbation: Options for Evolving Fragments
Drug Discovery Today: Technologies 2021read online